Bue-Valleskey J - Search Results

1

Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study.

Heise T, Linnebjerg H, Coutant D, LaBell E, Zijlstra E, Kapitza C, Bue-Valleskey J, Zhang Q, Dellva MA, Leohr J. Heise T, et al. Among authors: bue valleskey j. Diabetes Obes Metab. 2020 Oct;22(10):1789-1798. doi: 10.1111/dom.14094. Epub 2020 Jun 18. Diabetes Obes Metab. 2020. PMID: 32436641 Free PMC article. Clinical Trial.

2

Dose selection using a semi-mechanistic integrated glucose-insulin-glucagon model: designing phase 2 trials for a novel oral glucokinase activator.

Zhang X, Schneck K, Bue-Valleskey J, Yeo KP, Heathman M, Sinha V. Zhang X, et al. J Pharmacokinet Pharmacodyn. 2013 Feb;40(1):53-65. doi: 10.1007/s10928-012-9286-9. Epub 2012 Dec 22. J Pharmacokinet Pharmacodyn. 2013. PMID: 23263772 Clinical Trial.

3

Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5.

Buse JB, Rodbard HW, Trescoli Serrano C, Luo J, Ivanyi T, Bue-Valleskey J, Hartman ML, Carey MA, Chang AM; IMAGINE 5 Investigators. Buse JB, et al. Diabetes Care. 2016 Jan;39(1):92-100. doi: 10.2337/dc15-1531. Epub 2015 Nov 17. Diabetes Care. 2016. PMID: 26577417 Clinical Trial.

4

Basal insulin peglispro versus insulin glargine in insulin-naïve type 2 diabetes: IMAGINE 2 randomized trial.

Davies MJ, Russell-Jones D, Selam JL, Bailey TS, Kerényi Z, Luo J, Bue-Valleskey J, Iványi T, Hartman ML, Jacobson JG, Jacober SJ; IMAGINE 2 Study Investigators. Davies MJ, et al. Diabetes Obes Metab. 2016 Nov;18(11):1055-1064. doi: 10.1111/dom.12712. Epub 2016 Aug 12. Diabetes Obes Metab. 2016. PMID: 27349219 Free PMC article. Clinical Trial.

5

Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trials.

Ginsberg H, Cariou B, Orchard T, Chen L, Luo J, Bastyr EJ 3rd, Bue-Valleskey J, Chang AM, Ivanyi T, Jacober SJ, Hoogwerf BJ. Ginsberg H, et al. Diabetes Obes Metab. 2016 Nov;18(11):1089-1092. doi: 10.1111/dom.12754. Epub 2016 Sep 14. Diabetes Obes Metab. 2016. PMID: 27486125 Clinical Trial.

6

A randomized clinical trial of basal insulin peglispro vs NPH in insulin-naïve patients with type 2 diabetes: the IMAGINE 6 trial.

Grunberger G, Chen L, Rodriguez A, Tinahones FJ, Jacober SJ, Bue-Valleskey J; IMAGINE 6 Investigators. Grunberger G, et al. Diabetes Obes Metab. 2016 Oct;18 Suppl 2:34-42. doi: 10.1111/dom.12743. Diabetes Obes Metab. 2016. PMID: 27723225 Clinical Trial.

7

Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes.

Cusi K, Sanyal AJ, Zhang S, Hoogwerf BJ, Chang AM, Jacober SJ, Bue-Valleskey JM, Higdon AN, Bastyr EJ 3rd, Haupt A, Hartman ML. Cusi K, et al. Among authors: bue valleskey jm. Diabetes Obes Metab. 2016 Oct;18 Suppl 2:50-58. doi: 10.1111/dom.12751. Diabetes Obes Metab. 2016. PMID: 27723227

8

Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes.

Cusi K, Sanyal AJ, Zhang S, Hartman ML, Bue-Valleskey JM, Hoogwerf BJ, Haupt A. Cusi K, et al. Among authors: bue valleskey jm. Diabetes Obes Metab. 2017 Nov;19(11):1630-1634. doi: 10.1111/dom.12973. Epub 2017 Jun 22. Diabetes Obes Metab. 2017. PMID: 28417532

9

Cytokeratin-18 and enhanced liver fibrosis scores in type 1 and type 2 diabetes and effects of two different insulins.

Sanyal A, Cusi K, Hartman ML, Zhang S, Bastyr EJ 3rd, Bue-Valleskey JM, Chang AM, Haupt A, Jacober SJ, Konrad RJ, Zhang Q, Hoogwerf BJ. Sanyal A, et al. Among authors: bue valleskey jm. J Investig Med. 2018 Mar;66(3):661-668. doi: 10.1136/jim-2017-000609. Epub 2017 Nov 21. J Investig Med. 2018. PMID: 29167192 Clinical Trial.

10

Ultra-Rapid Lispro Improves Postprandial Glucose Control and Time in Range in Type 1 Diabetes Compared to Lispro: PRONTO-T1D Continuous Glucose Monitoring Substudy.

Malecki MT, Cao D, Liu R, Hardy T, Bode B, Bergenstal RM, Bue-Valleskey J. Malecki MT, et al. Among authors: bue valleskey j. Diabetes Technol Ther. 2020 Nov;22(11):853-860. doi: 10.1089/dia.2020.0129. Epub 2020 Jun 10. Diabetes Technol Ther. 2020. PMID: 32453647 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page